5-exo,6-endo,7-exo,8-endo-5,6,7,8-tetra(chloroMethyl)-bicyclo[2.2.2]oct-2-ene
![]() |
- $544 - $1826
- Product name: 5-exo,6-endo,7-exo,8-endo-5,6,7,8-tetra(chloroMethyl)-bicyclo[2.2.2]oct-2-ene
- CAS: 75073-78-8
- MF: C12H16Cl4
- MW: 302.07
- EINECS:807-222-4
- MDL Number:MFCD28098252
- Synonyms:5-exo,6-endo,7-exo,8-endo-5,6,7,8-tetra(chloroMethyl)-bicyclo[2.2.2]oct-2-ene;5,6,7,8-Tetrakis(chloromethyl)-bicyclo[2.2.2]oct-2-ene;Bicyclo[2.2.2]oct-2-ene, 5,6,7,8-tetrakis(chloromethyl)-, stereoisomer
3 prices
Selected condition:
Brand
- Matrix Scientific
Package
- 500mg
- 1g
- 5g
- ManufacturerMatrix Scientific
- Product number116210
- Product description5,6,7,8-Tetrakis(chloromethyl)-bicyclo[2.2.2]oct-2-ene >95%
- Packaging5g
- Price$1826
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number116210
- Product description5,6,7,8-Tetrakis(chloromethyl)-bicyclo[2.2.2]oct-2-ene >95%
- Packaging1g
- Price$730
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number116210
- Product description5,6,7,8-Tetrakis(chloromethyl)-bicyclo[2.2.2]oct-2-ene >95%
- Packaging500mg
- Price$544
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Matrix Scientific | 116210 | 5,6,7,8-Tetrakis(chloromethyl)-bicyclo[2.2.2]oct-2-ene >95% | 5g | $1826 | 2021-12-16 | Buy |
Matrix Scientific | 116210 | 5,6,7,8-Tetrakis(chloromethyl)-bicyclo[2.2.2]oct-2-ene >95% | 1g | $730 | 2021-12-16 | Buy |
Matrix Scientific | 116210 | 5,6,7,8-Tetrakis(chloromethyl)-bicyclo[2.2.2]oct-2-ene >95% | 500mg | $544 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): |
![]() |
|||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | |||||||||||||||||||||||||||||||||||||||||||||||||
Hazard statements: |
|
|||||||||||||||||||||||||||||||||||||||||||||||||
Precautionary statements: |
|